Jeffrey P. Staab

Dr. Jeffrey P. Staab


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2017 in Journal of Vestibular Research
Verified
Journal Article
Open access
PDF file
JSJeffrey P. Staab
Jeffrey P. Staab
AEAnnegret Eckhardt-Henn
Annegret Eckhardt-Henn
AHArata Horii
Arata Horii
RJRolf Jacob
Rolf Jacob
MSMichael Strupp
Michael Strupp
ABAdolfo Bronstein
Adolfo Bronstein
This paper presents diagnostic criteria for persistent postural-perceptual dizziness (PPPD) to be included in the International Classification of Vestibular Disorders (ICVD). The term PPPD is new, but the disorder is not. Its diagnostic criteria were

5 December 2017 in Practical Neurology
Verified
Journal Article
Open access
PDF file
SPStoyan Popkirov
Stoyan Popkirov
JSJeffrey P. Staab
Jeffrey P. Staab
JSJ. R. Stone
J. R. Stone
Persistent postural-perceptual dizziness (PPPD) is a newly defined diagnostic syndrome that unifies key features of chronic subjective dizziness, phobic postural vertigo and related disorders. It describes a common chronic dysfunction of the vestibular system and brain that produces persistent dizziness, non-spinning vertigo and/or unsteadiness. The disorder constitutes a long-term maladaptation to a neuro-otological, medical or psychological event that triggered vestibular symptoms, and is usefully considered within the spectrum of other functional neurological disorders. While diagnostic tests and conventional imaging usually remain negative, patients with PPPD present in a characteristic way that maps on to positive diagnostic criteria. Patients often develop secondary functional gait disorder, anxiety, avoidance behaviour and severe disability. Once recognised, PPPD can be managed with effective communication and tailored treatment strategies, including specialised physical therapy (vestibular rehabilitation), serotonergic medications and cognitive-behavioural therapy.

1 August 2015 in Neurologic Clinics
Verified
Journal Article
Closed access
Alexandre BisdorffAlexandre Bisdorff
Alexandre Bisdorff
JSJeffrey P. Staab
Jeffrey P. Staab
DNDavid E. Newman-Toker
David E. Newman-Toker

1 October 2003 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
JSJeffrey P. Staab
Jeffrey P. Staab
MRMichael J. Ruckenstein
Michael J. Ruckenstein

1 September 2012 in Otology & Neurotology
Verified
Journal Article
Closed access
BNBrian A. Neff
Brian A. Neff
JSJeffrey P. Staab
Jeffrey P. Staab
SEScott D. Eggers
Scott D. Eggers
MCMatthew L. Carlson
Matthew L. Carlson
WSWilliam R. Schmitt
William R. Schmitt
NSNeil T. Shepard
Neil T. Shepard
To compare presentations of Ménière's disease (MD), vestibular migraine (VM), and Ménière's disease plus vestibular migraine (MDVM), with and without comorbid chronic subjective dizziness (CSD). Retrospective review with diagnosis confirmed by consensus conference of investigators using published criteria for MD, VM, and CSD. Ambulatory, tertiary dizziness clinic. Approximately 147 consecutive patients with diagnoses of MD, VM, or MDVM, with/without comorbid CSD. Diagnostic consultation. Similarities and differences between diagnostic groups in demographics; symptoms; and results of neurotologic, audiometric, and vestibular laboratory assessments. Seventy-six patients had MD, 55 MD alone. Ninety-two patients had VM, 71 VM alone. Twenty-one patients had MDVM, representing about one-quarter of those diagnosed with MD or VM. Clinical features thought to differentiate VM from MD were found in all groups. Twenty-seven patients with VM (38%) had ear complaints (subjective hearing loss, aural pressure, and tinnitus) during episodes of vestibular symptoms and headache, including 10 (37%) with unilateral symptoms. Conversely, 27 patients with MD alone (49%) had headaches with migraine features that did not meet full IHS diagnostic criteria, migrainous symptoms (photophobia, headache with vomiting), or first-degree relative with migraine. Including MDVM patients, 59% (45/76) of all patients with MD had migrainous features. Thirty-two patients had CSD; most (29; 91%) were in the VM group. Comorbidity was common between MD and VM, and their symptoms overlapped. More specific diagnostic criteria are needed to differentiate these diseases and address their coexistence. CSD co-occurred with VM but was rarely seen with MD.

1 February 2017 in Current Opinion in Neurology
Verified
Journal Article
Closed access
MDMarianne Dieterich
Marianne Dieterich
JSJeffrey P. Staab
Jeffrey P. Staab
Purpose of review: Functional dizziness is the new term for somatoform or psychogenic dizziness. The aim of this study is to review arguments for the new nomenclature, clinical features, possible pathomechanisms, and comorbidities of functional dizziness. Recent findings: The prevalence of functional dizziness as a primary cause of vestibular symptoms amounts to 10% in neuro-otology centers. Rates of psychiatric comorbidity in patients with structural vestibular syndromes are much higher with nearly 50% and with highest rates in patients with vestibular migraine, vestibular paroxysmia, and Ménière's disease. Pathophysiologic processes seem to include precipitating events that trigger anxiety-related changes in postural strategies with an increased attention to head and body motion and a cocontraction of leg muscles. Personality traits with high levels of neuroticism and low levels of extraversion appear as risk factors for anxiety and depressive disorders and increased morbidity in functional disorders. Summary: Correct and early diagnosis of functional dizziness, as primary cause or secondary disorder after a structural vestibular syndrome, is very important to prevent further chronification and enable adequate treatment. Treatment plans that include patient education, vestibular rehabilitation, cognitive and behavioral therapies, and medications substantially reduce morbidity and offer the potential for sustained remission when applied systematically.